Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Pain Management Pillars for the Clinical Nurse Specialist: Summary of National Association of Clinical Nurse Specialists Opioid Pain Management Task Force.

Klaess CC, Urton M, Whitehead P, Rosier PK, Burnie J, Michel M.

Clin Nurse Spec. 2019 May/Jun;33(3):136-145. doi: 10.1097/NUR.0000000000000449.

PMID:
30946111
2.

The Incorporation of Host Proteins into the External HIV-1 Envelope.

Burnie J, Guzzo C.

Viruses. 2019 Jan 20;11(1). pii: E85. doi: 10.3390/v11010085. Review.

3.

Management of Opioid Overdose Victims Outside the Emergency Department: A Case Discussion.

Clark A, Burnie J, Johann R, Baker R, Hassert C.

J Emerg Nurs. 2019 Jan;45(1):12-15. doi: 10.1016/j.jen.2018.08.010. Epub 2018 Sep 28. Review. No abstract available.

PMID:
30274666
4.

Enhancement of antibiotic susceptibility of Stenotrophomonas maltophilia using a polyclonal antibody developed against an ABC multidrug efflux pump.

Al-Hamad A, Burnie J, Upton M.

Can J Microbiol. 2011 Oct;57(10):820-8. doi: 10.1139/w11-076. Epub 2011 Sep 26.

PMID:
21942332
5.

Molecular cloning and characterization of SmrA, a novel ABC multidrug efflux pump from Stenotrophomonas maltophilia.

Al-Hamad A, Upton M, Burnie J.

J Antimicrob Chemother. 2009 Oct;64(4):731-4. doi: 10.1093/jac/dkp271. Epub 2009 Jul 29.

PMID:
19643774
6.

Efungumab and caspofungin: pre-clinical data supporting synergy.

Hodgetts S, Nooney L, Al-Akeel R, Curry A, Awad S, Matthews R, Burnie J.

J Antimicrob Chemother. 2008 May;61(5):1132-9. doi: 10.1093/jac/dkn075. Epub 2008 Feb 25.

PMID:
18299636
7.

A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis.

Pachl J, Svoboda P, Jacobs F, Vandewoude K, van der Hoven B, Spronk P, Masterson G, Malbrain M, Aoun M, Garbino J, Takala J, Drgona L, Burnie J, Matthews R; Mycograb Invasive Candidiasis Study Group.

Clin Infect Dis. 2006 May 15;42(10):1404-13. Epub 2006 Apr 12.

8.

Fungal heat-shock proteins in human disease.

Burnie JP, Carter TL, Hodgetts SJ, Matthews RC.

FEMS Microbiol Rev. 2006 Jan;30(1):53-88. Review.

9.

Recommendations for managing Aspergillus osteomyelitis and joint infections based on a review of the literature.

Kirby A, Hassan I, Burnie J.

J Infect. 2006 Jun;52(6):405-14. Epub 2005 Oct 18. Review.

PMID:
16239033
10.

Differential growth of epidemic methicillin-resistant Staphylococcus aureus in vancomycin.

Alshami I, Matthews RC, Burnie JF, Asghar AH, Momenah AM.

Br J Biomed Sci. 2005;62(3):109-13.

PMID:
16196455
11.

Human recombinant antibody to HSP90: a natural partner in combination therapy.

Matthews RC, Burnie JP.

Curr Mol Med. 2005 Jun;5(4):403-11. Review.

PMID:
15977996
12.
13.

An outbreak of imipenem-resistant Pseudomonas aeruginosa in an intensive care unit.

Majumdar S, Kirby A, Berry N, Williams C, Hassan I, Eddleston J, Burnie JP.

J Hosp Infect. 2004 Oct;58(2):160-1. No abstract available.

PMID:
15474190
14.

The diagnosis of hepatosplenic candidiasis by DNA analysis of tissue biopsy and serum.

Kirby A, Chapman C, Hassan C, Burnie J.

J Clin Pathol. 2004 Jul;57(7):764-5.

15.

Recombinant antibodies: a natural partner in combinatorial antifungal therapy.

Matthews RC, Burnie JP.

Vaccine. 2004 Feb 17;22(7):865-71. Review.

PMID:
15040939
16.

Genetically recombinant antibodies: new therapeutics against candidiasis.

Burnie J, Matthews R.

Expert Opin Biol Ther. 2004 Feb;4(2):233-41. Review.

PMID:
14998780
17.

The role of antibodies against hsp90 in the treatment of fungal infections.

Burnie J, Matthews R.

Drug News Perspect. 2003 May;16(4):205-10. Review.

PMID:
12942149
18.

Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90.

Matthews RC, Rigg G, Hodgetts S, Carter T, Chapman C, Gregory C, Illidge C, Burnie J.

Antimicrob Agents Chemother. 2003 Jul;47(7):2208-16.

19.

Clostridium difficile, atopy and wheeze during the first year of life.

Woodcock A, Moradi M, Smillie FI, Murray CS, Burnie JP, Custovic A.

Pediatr Allergy Immunol. 2002 Oct;13(5):357-60.

PMID:
12431195
20.

Neutralising human recombinant antibodies to human cytomegalovirus glycoproteins gB and gH.

Nejatollahi F, Hodgetts SJ, Vallely PJ, Burnie JP.

FEMS Immunol Med Microbiol. 2002 Nov 15;34(3):237-44.

21.
22.

Identification of ABC transporters in vancomycin-resistant Enterococcus faecium as potential targets for antibody therapy.

Burnie J, Carter T, Rigg G, Hodgetts S, Donohoe M, Matthews R.

FEMS Immunol Med Microbiol. 2002 Jul 12;33(3):179-89.

23.

Identification of an immunodominant drug efflux pump in Burkholderia cepacia.

Wigfield SM, Rigg GP, Kavari M, Webb AK, Matthews RC, Burnie JP.

J Antimicrob Chemother. 2002 Apr;49(4):619-24.

PMID:
11909835
24.

Recurrent Escherichia coli bacteraemia in a patient with chronic renal failure.

Adedeji A, Subudhi CP, Hutchison AJ, Burnie JP, Kerr JR.

Nephrol Dial Transplant. 2001 Dec;16(12):2429-30. No abstract available.

PMID:
11733641
25.

Antifungal antibodies: a new approach to the treatment of systemic candidiasis.

Matthews R, Burnie J.

Curr Opin Investig Drugs. 2001 Apr;2(4):472-6. Review.

PMID:
11566001
26.

The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections.

Polonelli L, Casadevall A, Han Y, Bernardis F, Kirkland TN, Matthews RC, Adriani D, Boccanera M, Burnie JP, Cassone A, Conti S, Cutler JE, Frazzi R, Gregory C, Hodgetts S, Illidge C, Magliani W, Rigg G, Santoni G.

Med Mycol. 2000;38 Suppl 1:281-92. Review.

PMID:
11204156
27.

An association between sudden infant death syndrome (SIDS) and Helicobacter pylori infection.

Kerr JR, Al-Khattaf A, Barson AJ, Burnie JP.

Arch Dis Child. 2000 Nov;83(5):429-34.

28.

Analysis of 42 cases of septicemia caused by an epidemic strain of methicillin-resistant Staphylococcus aureus: evidence of resistance to vancomycin.

Burnie J, Matthews R, Jiman-Fatami A, Gottardello P, Hodgetts S, D'arcy S.

Clin Infect Dis. 2000 Sep;31(3):684-9. Epub 2000 Oct 4.

PMID:
11017816
29.

A PCR-based approach to sequence the Candida tropicalis HSP90 gene.

Santhanam J, Burnie JP.

FEMS Immunol Med Microbiol. 2000 Sep;29(1):35-8.

30.

Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections.

Burnie JP, Matthews RC, Carter T, Beaulieu E, Donohoe M, Chapman C, Williamson P, Hodgetts SJ.

Infect Immun. 2000 Jun;68(6):3200-9.

31.

Analysis of antibody response to Cryptococcus neoformans in five patients with AIDS and cryptococcosis by immunoblotting.

Lamura L, Matthews RC, Barchiesi F, Donahoe M, Burnie JP, Scalise G.

J Infect. 2000 Jan;40(1):64-8.

PMID:
10762114
32.

Nosocomial fungal infection: diagnosis and typing.

Barnes RA, Rogers TR, Pittet D, Burnie J, Haynes KA.

J Hosp Infect. 1999 Dec;43 Suppl:S215-8. Review. No abstract available.

PMID:
10658782
33.

The Bpel locus encodes type III secretion machinery in Bordetella pertussis.

Kerr JR, Rigg GP, Matthews RC, Burnie JP.

Microb Pathog. 1999 Dec;27(6):349-67.

PMID:
10588908
34.
35.

Stress proteins in fungal diseases.

Matthews RC, Maresca B, Burnie JP, Cardona A, Carratu L, Conti S, Deepe GS, Florez AM, Franceschelli S, Garcia E, Gargano LS, Kobayashi GS, McEwen JG, Ortiz BL, Oviedo AM, Polonelli L, Ponton J, Restrepos A, Storlazzi A.

Med Mycol. 1998;36 Suppl 1:45-51. Review.

PMID:
9988491
36.

Is infection control an academic study?

Burnie JP.

J Hosp Infect. 1999 Jan;41(1):7-10. Review.

PMID:
9949958
37.

The role of antibodies in protection against candidiasis.

Matthews R, Burnie J.

Res Immunol. 1998 May-Jun;149(4-5):343-52; discussion 496-9. Review. No abstract available.

PMID:
9720952
38.

The renaissance of antibody therapy.

Burnie JP, Matthews RC.

J Antimicrob Chemother. 1998 Mar;41(3):319-22. Review. No abstract available.

PMID:
9578156
39.

Epitope mapping Candida albicans proteinase (SAP 2).

Ghadjari A, Matthews RC, Burnie JP.

FEMS Immunol Med Microbiol. 1997 Oct;19(2):115-23.

41.
42.

Candida inconspicua, a fluconazole-resistant pathogen in patients infected with human immunodeficiency virus.

Baily GG, Moore CB, Essayag SM, de Wit S, Burnie JP, Denning DW.

Clin Infect Dis. 1997 Jul;25(1):161-3. No abstract available.

PMID:
9243058
43.
44.

Semiquantitative polymerase chain reaction enzyme immunoassay for diagnosis of disseminated candidiasis.

Burnie JP, Golbang N, Matthews RC.

Eur J Clin Microbiol Infect Dis. 1997 May;16(5):346-50.

PMID:
9228473
45.

Ciprofloxacin-resistant Staphylococcus epidermidis and hands.

Burnie JP, Loudon KW.

Lancet. 1997 Mar 1;349(9052):649. No abstract available.

PMID:
9057750
46.

Over-expression of Saccharomyces cerevisiae hsp90 enhances the virulence of this yeast in mice.

Hodgetts S, Matthews R, Morrissey G, Mitsutake K, Piper P, Burnie J.

FEMS Immunol Med Microbiol. 1996 Dec 31;16(3-4):229-34.

PMID:
9116640
47.

Sensitive and universal method for microbial DNA extraction from blood products.

Golbang N, Burnie JP, Klapper PE, Bostock A, Williamson P.

J Clin Pathol. 1996 Oct;49(10):861-3.

48.

Antibodies against Candida: potential therapeutics?

Matthews R, Burnie J.

Trends Microbiol. 1996 Sep;4(9):354-8. Review.

PMID:
8885170
49.
50.

Defining antibody targets in Streptococcus oralis infection.

Burnie JP, Brooks W, Donohoe M, Hodgetts S, al-Ghamdi A, Matthews RC.

Infect Immun. 1996 May;64(5):1600-8.

Supplemental Content

Loading ...
Support Center